Super-sensitive detection of BCR-ABL mutants driving CML recurrence
Ended Project Grant Awarded Last action
- Award ID
- R43CA235891
- Recipient
-
Genetag Technology, Inc. UEI N78BHV2RJKJ8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $242,611
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Place of performance
- Atlanta, GA 30341, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $242,611 |
Quick answers
Who received award R43CA235891?
R43CA235891 was awarded to Genetag Technology, Inc. by National Cancer Institute (National Institutes of Health) on September 3, 2019.
How much is award R43CA235891 worth?
$242,611 has been obligated on R43CA235891.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award